We are live on ! Find out more
CTA

Carillon Tower Advisers Portfolio holdings

AUM $16.4B
1-Year Est. Return 64.75%
This Fund
S&P 500
This Quarter Est. Return
+6.94%
1 Year Est. Return
+64.75%
3 Year Est. Return
+147.06%
5 Year Est. Return
10 Year Est. Return
AUM
$14.6B
AUM Growth
+$423M
Cap. Flow
-$220M
Cap. Flow %
-1.51%
Top 10 Hldgs %
9.47%
Holding
503
New
43
Increased
174
Reduced
117
Closed
38

Top Buys

Rank Stock Value
1
MRSH
Marsh
MRSH
+$61.3M
2
XEL icon
Xcel Energy
XEL
+$51.9M
3
WEC icon
WEC Energy
WEC
+$43.5M
4
AMD icon
Advanced Micro Devices
AMD
+$42.7M
5
CNC icon
Centene
CNC
+$42.6M

Sector Composition

Rank Sector Weight
1 Healthcare 18.46%
2 Technology 18.13%
3 Industrials 16.11%
4 Consumer Discretionary 13.66%
5 Financials 9.19%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
SRI icon
401
Stoneridge
SRI
$200M
$4.22M 0.03%
133,733
+2,700
+2% +$79.9K
MEDP icon
402
Medpace
MEDP
$16.3B
$4.16M 0.03%
63,525
+4,575
+8% +$264K
CBM
403
DELISTED
Cambrex Corporation
CBM
$4.02M 0.03%
85,930
+1,750
+2% +$73.4K
KEX icon
404
Kirby Corp
KEX
$7.01B
$4M 0.03%
50,575
-75,575
-60% -$6.07M
AVTA
405
DELISTED
Avantax, Inc. Common Stock
AVTA
$3.84M 0.03%
126,525
+2,575
+2% +$84.7K
COO icon
406
Cooper Companies
COO
$14.2B
$3.81M 0.03%
45,200
GHDX
407
DELISTED
Genomic Health, Inc.
GHDX
$3.8M 0.03%
65,346
+1,300
+2% +$77K
IRBT
408
DELISTED
iRobot
IRBT
$3.75M 0.03%
40,979
+650
+2% +$65.9K
VRTU
409
DELISTED
Virtusa Corporation
VRTU
$3.68M 0.03%
82,863
+16,450
+25% +$803K
PLXS icon
410
Plexus
PLXS
$6.43B
$3.68M 0.03%
63,004
+30,325
+93% +$1.75M
KLAC icon
411
KLA
KLAC
$222B
$3.62M 0.02%
306,000
+89,000
+41% +$1.03M
PLAY icon
412
Dave & Buster's
PLAY
$357M
$3.59M 0.02%
88,725
-802,191
-90% -$40.8M
IONS icon
413
Ionis Pharmaceuticals
IONS
$8.93B
$3.57M 0.02%
55,500
-147,825
-73% -$10.4M
TPIC
414
DELISTED
TPI Composites
TPIC
$3.57M 0.02%
+144,312
New +$3.69M
PVH icon
415
PVH
PVH
$4.07B
$3.56M 0.02%
37,600
PLUS icon
416
ePlus
PLUS
$2.43B
$3.56M 0.02%
103,124
+2,050
+2% +$85.2K
GIC icon
417
Global Industrial
GIC
$1.38B
$3.55M 0.02%
160,375
+27,775
+21% +$609K
IPHI
418
DELISTED
INPHI CORPORATION
IPHI
$3.48M 0.02%
69,439
+1,375
+2% +$64K
LIND icon
419
Lindblad Expeditions
LIND
$1.95B
$3.48M 0.02%
193,705
+3,925
+2% +$64.4K
CTRE icon
420
CareTrust REIT
CTRE
$10B
$3.47M 0.02%
145,799
+2,950
+2% +$71.5K
AX icon
421
Axos Financial
AX
$5.58B
$3.46M 0.02%
126,794
+2,600
+2% +$76.5K
HCSG icon
422
Healthcare Services Group
HCSG
$1.61B
$3.39M 0.02%
111,789
+17,050
+18% +$563K
VRNT
423
DELISTED
Verint Systems
VRNT
$3.36M 0.02%
+122,491
New +$3.68M
CAKE icon
424
Cheesecake Factory
CAKE
$5.03B
$3.33M 0.02%
76,164
+1,500
+2% +$70.1K
EGRX
425
DELISTED
Eagle Pharmaceuticals, Inc.
EGRX
$3.31M 0.02%
59,396
+5,900
+11% +$308K

Similar funds

Carillon Tower Advisers's Q2 2019 Portfolio in Review

As of Q2 2019, Carillon Tower Advisers held 503 positions worth $14.6B, up 3% from $14.1B the previous quarter. Its ten largest holdings account for 9.5% of the portfolio.

Carillon Tower Advisers's Q2 2019 filing shows 43 new, 174 increased, 117 reduced and 38 closed positions. Its largest new stake was Marsh: 640,125 shares worth $63.9M. The largest sale was Tableau Software, Inc., an estimated $120M.

By sector, the portfolio is most concentrated in Healthcare at 18% of assets, up from 18% a quarter earlier, followed by Technology and Industrials.

  • Carillon Tower Advisers's largest Q2 2019 buy was Marsh: 640,125 shares worth $63.9M.
  • Carillon Tower Advisers added most to Xcel Energy in Q2 2019, an estimated $51.9M increase.
  • Carillon Tower Advisers's biggest Q2 2019 reduction was ServiceNow, cutting an estimated $55.7M.
  • Carillon Tower Advisers fully exited Tableau Software, Inc. in Q2 2019, selling an estimated $120M.
  • Carillon Tower Advisers's ten largest holdings make up 9.5% of its $14.6B portfolio in Q2 2019.
  • Carillon Tower Advisers opened 43 new positions and closed 38 in Q2 2019.
  • Carillon Tower Advisers's portfolio value rose 3% quarter-over-quarter to $14.6B.

Based on Carillon Tower Advisers's 13F filing for Q2 2019, filed 8 Aug 2019.